anti-CLDN6 monoclonal antibody ASP1650
Term · Oncology and biomedicine · MLC-T-ONC-010518
A monoclonal antibody directed against the cell surface protein claudin 6 (CLDN6), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-CLDN6 monoclonal antibody ASP1650 binds to CLDN-6 and may stimulate the immune system to exert both an antibody-dependent cellular cytotoxicity (ADCC) and a complement-dependent cytotoxicity (CDC) mediated immune response against CLDN-6-expressing tumor cells. This may inhibit tumor cell growth. CLDN-6, a tight-junction protein and embryonic antigen, is expressed on a variety of tumor cells but is not expressed on normal, healthy adult cells.
| Identifier | MLC-T-ONC-010518 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-Claudin 6 monoclonal antibody ASP1650 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010518",
"term": "anti-CLDN6 monoclonal antibody ASP1650",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against the cell surface protein claudin 6 (CLDN6), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-CLDN6 monoclonal antibody ASP1650 binds to CLDN-6 and may stimulate the immune system to exert both an antibody-dependent cellular cytotoxicity (ADCC) and a complement-dependent cytotoxicity (CDC) mediated immune response against CLDN-6-expressing tumor cells. This may inhibit tumor cell growth. CLDN-6, a tight-junction protein and embryonic antigen, is expressed on a variety of tumor cells but is not expressed on normal, healthy adult cells.",
"synonyms": [
"anti-Claudin 6 monoclonal antibody ASP1650"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cldn6-monoclonal-antibody-asp1650/"
}
Record 1,609 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.